MEDLINE INC-CL A Earnings Dividend

MEDLINE INC-CL A’s revenue jumped 11.38% since last year same period to $7115Mn in the Q3 2025. On a quarterly growth basis, MEDLINE INC-CL A has generated 3.33% jump in its revenue since last 3-months.

MEDLINE INC-CL A’s net profit fell -0.62% since last year same period to $322Mn in the Q3 2025. On a quarterly growth basis, MEDLINE INC-CL A has generated -3.3% fall in its net profits since last 3-months.

MEDLINE INC-CL A’s net profit margin fell -10.77% since last year same period to 4.53% in the Q3 2025. On a quarterly growth basis, MEDLINE INC-CL A has generated -6.42% fall in its net profit margins since last 3-months.

MEDLINE INC-CL A’s earning per share (EPS) estimates for the current quarter stand at 0.29 - a 20.83% jump from last quarter’s estimates.

MEDLINE INC-CL A’s earning per share (EPS) estimates for the current year stand at 0.29.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. MEDLINE INC-CL A’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. MEDLINE INC-CL A’s return on equity (ROE) stands at 0.07.